1. Home
  2. MGRC vs ADPT Comparison

MGRC vs ADPT Comparison

Compare MGRC & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$110.01

Market Cap

2.7B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.27

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGRC
ADPT
Founded
1979
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MGRC
ADPT
Price
$110.01
$18.27
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$143.00
$16.70
AVG Volume (30 Days)
117.5K
2.0M
Earning Date
02-25-2026
02-05-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
N/A
EPS
5.90
N/A
Revenue
$931,222,000.00
$252,754,000.00
Revenue This Year
$5.46
$50.86
Revenue Next Year
$4.31
$0.53
P/E Ratio
$18.77
N/A
Revenue Growth
4.78
42.57
52 Week Low
$94.99
$6.26
52 Week High
$129.93
$20.76

Technical Indicators

Market Signals
Indicator
MGRC
ADPT
Relative Strength Index (RSI) 49.25 54.89
Support Level $112.61 $16.55
Resistance Level $118.66 $19.42
Average True Range (ATR) 3.25 0.94
MACD 0.20 0.09
Stochastic Oscillator 31.24 69.48

Price Performance

Historical Comparison
MGRC
ADPT

About MGRC McGrath RentCorp

McGrath RentCorp is a rental company. It is comprised of four reportable business segments namely Modular building segment (Mobile Modular); Portable storage container segment (Portable Storage); Electronic test equipment segment (TRS-RenTelco); and its classroom manufacturing business selling modular buildings used as classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: